Statistics on Biotechnology Use  
Results by fields of operation
Company sector. Biotechnology results by main variables and no. of employees. 
Unidades: specified in variables

,Fewer than 250 employees,250 or more employees,Total 2020,
No. of companies carrying out R&D in Biotechnology,1.126,108,1.233,
%Companies according to biotechnology used: Genetic code,30,9,40,2,31,7,
%Companies according to biotechnology used: Functional units,37,4,50,4,38,5,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,21,6,34,5,22,8,
%Companies according to biotechnology used: Bioprocesses,51,7,71,53,4,
%Companies according to biotechnology used: Sub-cellular organisms,7,8,16,8,8,6,
%Companies according to biotechnology used: Bio-computing,22,2,22,3,22,3,
%Companies according to biotechnology used: Nanobiotechnology,10,5,12,1,10,6,
%Companies according to biotechnology used: Other,14,7,9,3,14,2,
Companies in which biotechnology activities are: Main and/or exclusive,590,25,615,
Companies in which biotechnology activities are: A secondary line of business,156,22,178,
Companies in which biotechnology activities are: A tool necessary for production,379,61,440,
%Company by field(s) of ultimate application of biotechnology use: Human Health,46,2,46,5,46,3,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,16,9,9,3,16,2,
%Company by field(s) of ultimate application of biotechnology use: Food products,31,7,35,6,32,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,25,6,14,1,24,6,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,3,17,7,15,5,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,1,11,1,12,9,
Personnel in R&D in biotechnology (no. of persons),9.325,4.119,13.444,
Personnel in R&D in biotechnology (no. of persons): Researchers,5.272,2.106,7.378,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.053,2.013,6.066,
Personnel in R&D in biotechnology (no. of persons): women,4.869,2.632,7.501,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.752,1.299,4.052,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.117,1.333,3.450,
Personnel in R&D in biotechnology (FTE),6.291,5,3.110,4,9.401,9,
Personnel in R&D in biotechnology (FTE): Researchers,3.811,8,1.586,5,5.398,3,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.479,7,1.523,9,4.003,6,
Personnel in R&D in biotechnology (FTE): women,3.385,8,2.040,5,5.426,2,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.020,5,996,3.016,4,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.365,3,1.044,5,2.409,8,
Internal expenditure on R&D (thousands of euros),586.635,310.698,897.333,
1) By nature of the expense: Current expenses,520.977,296.432,817.409,
1.1) Remuneration to researchers,182.849,112.856,295.705,
1.2) Remuneration to technicians and assistants,90.123,66.730,156.853,
1.3) Other current expenses,248.005,116.847,364.852,
2) By nature of the expense: Capital expenses,65.658,14.266,79.924,
2.1) Land and buildings,6.331,3.941,10.272,
2.2) Equipment and instruments,46.970,9.640,56.609,
2.3) Acquisition of specific R&D software,4.475,364,4.839,
2.4) Otros productos de propiedad intelectual específicos para I+D,7.882,321,8.203,
1.1) By origin of the funds: Own funds,406.605,206.492,613.097,
1.2) By origin of the funds: From companies,62.831,23.253,86.085,
1.3) By origin of the funds: Public Administration funds,71.590,20.550,92.140,
1.4) By origin of the funds: From Universities,548,306,853,
1.5) By origin of the funds: From non profit private institutions,2.496,2.185,4.682,
1.6) By origin of the funds: Foreign funds,42.564,57.912,100.476,
Purchase of R&D services in biotechnology (thousands of euros),48.478,36.533,85.011,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,23.128,31.114,54.243,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,25.350,5.419,30.768,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,40,9,22,4,39,2,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,11,5,14,11,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,12,9,8,4,12,5,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,10,8,11,2,10,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,14,7,10,3,14,3,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,17,4,7,5,16,5,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,15,2,13,1,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,31,36,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,47,2,41,46,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,3,15,9,19,
% Companies that have requested biotechnology patents in Biotechnology,17,3,17,7,17,3,
Number of patents requested,600,81,681,
% Companies with income of an international origin related to biotechnological activities,23,6,16,8,23,
% Turnover representing income of an international origin related to biotechnological activities,5,6,0,9,1,6,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,44,7,69,7,55,9,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,55,3,30,3,44,1,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,97,2,67,6,83,9,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,1,1,31,5,14,7,
% Income of an international origin related with activities according to the classification: Operating source abroad,0,7,0,9,0,8,
% Income of an international origin related with activities according to the classification: Other,1,1,0,0,6,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute